RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCOPUS

      Antibiotic Control Policies in South Korea, 2000-2013

      한글로보기

      https://www.riss.kr/link?id=A103573450

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract) kakao i 다국어 번역

      Antibiotic stewardship is a key strategy for limiting antibiotic resistance. Over the last decade the South Korean government has implemented a series of healthcare policies directed to this end, consisting of legislative separation of drug prescribing and dispensing, antibiotic utilization reviews, healthcare quality assessment, and public reporting. As a result, the proportion of antibiotic prescriptions for acute upper respiratory tract infections in primary healthcare facilities decreased from 72.9% in 2002 to 42.7% in 2013. However, no significant decrease in antibiotic resistance occurred over the same period in clinically important bacteria such as Streptococcus pneumoniae. These government-driven policies played a pivotal role in improving antibiotic use for outpatients and surgical patients in South Korea. However, to achieve long-lasting successful outcomes, coordinated efforts and communications among the stakeholders, including physicians and medical societies, are needed.
      번역하기

      Antibiotic stewardship is a key strategy for limiting antibiotic resistance. Over the last decade the South Korean government has implemented a series of healthcare policies directed to this end, consisting of legislative separation of drug prescribin...

      Antibiotic stewardship is a key strategy for limiting antibiotic resistance. Over the last decade the South Korean government has implemented a series of healthcare policies directed to this end, consisting of legislative separation of drug prescribing and dispensing, antibiotic utilization reviews, healthcare quality assessment, and public reporting. As a result, the proportion of antibiotic prescriptions for acute upper respiratory tract infections in primary healthcare facilities decreased from 72.9% in 2002 to 42.7% in 2013. However, no significant decrease in antibiotic resistance occurred over the same period in clinically important bacteria such as Streptococcus pneumoniae. These government-driven policies played a pivotal role in improving antibiotic use for outpatients and surgical patients in South Korea. However, to achieve long-lasting successful outcomes, coordinated efforts and communications among the stakeholders, including physicians and medical societies, are needed.

      더보기

      참고문헌 (Reference)

      1 송준영, "폐렴구균백신" 대한의사협회 57 (57): 780-788, 2014

      2 김남순, "급성 상기도 질환에서 일차의료의사의 항생제 처방에 영향을 주는 요인" 대한예방의학회 38 (38): 1-8, 2005

      3 World Health Organization, "World Health Day 2011. Combat drug resistance: no action today means no cure tomorrow"

      4 Haustein T, "Use of benchmarking and public reporting for infection control in four high-income countries" 11 : 471-481, 2011

      5 Cosgrove SE, "The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs" 42 (42): S82-S89, 2006

      6 이영숙, "Temporal decrease in overall antibiotic consumption accompanying antibiotic prescribing rate disclosure policy: evidence from analysis of national health insurance claims data in South Korea" 대한약학회 37 (37): 1295-1300, 2014

      7 Fung CH, "Systematic review: the evidence that publishing patient care performance data improves quality of care" 148 : 111-123, 2008

      8 Mölstad S, "Sustained reduction of antibiotic use and low bacterial resistance:10-year follow-up of the Swedish Strama programme" 8 : 125-132, 2008

      9 Huttner B, "Success stories of implementation of antimicrobial stewardship: a narrative review" 20 : 954-962, 2014

      10 Oh OH, "Study on total volume of systemic antibacterials used of human body (2008-2009)" KCDC 2010

      1 송준영, "폐렴구균백신" 대한의사협회 57 (57): 780-788, 2014

      2 김남순, "급성 상기도 질환에서 일차의료의사의 항생제 처방에 영향을 주는 요인" 대한예방의학회 38 (38): 1-8, 2005

      3 World Health Organization, "World Health Day 2011. Combat drug resistance: no action today means no cure tomorrow"

      4 Haustein T, "Use of benchmarking and public reporting for infection control in four high-income countries" 11 : 471-481, 2011

      5 Cosgrove SE, "The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs" 42 (42): S82-S89, 2006

      6 이영숙, "Temporal decrease in overall antibiotic consumption accompanying antibiotic prescribing rate disclosure policy: evidence from analysis of national health insurance claims data in South Korea" 대한약학회 37 (37): 1295-1300, 2014

      7 Fung CH, "Systematic review: the evidence that publishing patient care performance data improves quality of care" 148 : 111-123, 2008

      8 Mölstad S, "Sustained reduction of antibiotic use and low bacterial resistance:10-year follow-up of the Swedish Strama programme" 8 : 125-132, 2008

      9 Huttner B, "Success stories of implementation of antimicrobial stewardship: a narrative review" 20 : 954-962, 2014

      10 Oh OH, "Study on total volume of systemic antibacterials used of human body (2008-2009)" KCDC 2010

      11 Lee EK, "Study on the relationship of antibiotic use and resistance" Korea Food & Drug Administration 2002

      12 Song JH, "Spread of drug-resistant Streptococcus pneumoniae in Asian countries: Asian network for surveillance of resistant pathogens (ANSORP)study" 28 : 1206-1211, 1999

      13 Sabuncu E, "Significant reduction of antibiotic use in the community after a nationwide campaign in France, 2002-2007" 6 : e1000084-, 2009

      14 Health Insurance Review & Assessment Service, "Results of quality asessment of prescriptions in 2013"

      15 Health Insurance Review & Assessment Service, "Results of quality asessment of prescriptions in 2012"

      16 Chun CB, "Republic of Korea: Health system review" 11 : 1-184, 2009

      17 Health Insurance Review & Assessment Service, "Report of drug utilization review in the latter half of 2013"

      18 Rhee C, "Regulatory mandates for sepsis care--reasons for caution" 370 : 1673-1676, 2014

      19 Lee YS, "Private practitioners' antimicrobial prescription patterns for acute respiratory infections in children" 17 : 3-19, 1991

      20 Bae SM, "Prevalence of serotype and multidrug resistance of Streptococcus pneumoniae isolated from patients with community-acquired pneumonia" Public Health Wkly 573-578, 2014

      21 Lee SY, "Prevalence of penicillin-resistant Streptococcus pneumoniae and antimicrobial susceptibility of beta-hemolytic Streptococcus and Enterococcus" 4 : 44-51, 1986

      22 Cho HJ, "Prescription behaviours of office-based doctors to standardized common cold patients in Korea" 11 : 401-405, 2002

      23 Kim DS, "Physician’s belief on antibiotic use in upper respiratory tract infections" 5 : 33-41, 2011

      24 Kwon S, "Pharmaceutical reform and physician strikes in Korea: separation of drug prescribing and dispensing" 57 : 529-538, 2003

      25 Park S, "Patterns of antibiotics utilization in some respiratory diseases in clinics" 5 : 58-75, 1998

      26 송준영, "Outpatient-Based Pneumococcal Vaccine Campaign and Survey of Perceptions about Pneumococcal Vaccination in Patients and Doctors" 연세대학교의과대학 54 (54): 469-475, 2013

      27 SNUHMC Institute of Health Policy & Management, "Outcome evaluation models for the quality assessment of medical services"

      28 Organisation for Economic Co-operation and Development, "OECD Health Statistics 2014"

      29 Mangione-Smith R, "Measuring the quality of antibiotic prescribing for upper respiratory infections and bronchitis in 5 US health plans" 159 : 751-757, 2005

      30 Song JH, "Macrolide resistance and genotypic characterization of Streptococcus pneumoniae in Asian countries: a study of the Asian Network for Surveillance of Resistant Pathogens (ANSORP)" 53 : 457-463, 2004

      31 Kim HJ, "Lessons from Korea's pharmaceutical policy reform: the separation of medical institutions and pharmacies for outpatient care" 68 : 267-275, 2004

      32 Davey P, "Interventions to improve antibiotic prescribing practices for hospital inpatients" 4 : CD003543-, 2013

      33 Chahwakilian P, "Impact of the French campaign to reduce inappropriate ambulatory antibiotic use on the prescription and consultation rates for respiratory tract infections" 66 : 2872-2879, 2011

      34 Kim ES, "Impact of a national hospital evaluation program using clinical performance indicators on the use of surgical antibiotic prophylaxis in Korea" 16 : e187-e192, 2012

      35 Chow AW, "IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults" 54 : e72-e112, 2012

      36 Thompson PL, "Has UK guidance affected general practitioner antibiotic prescribing for otitis media in children?" 30 : 479-486, 2008

      37 이현주, "Efficacy and effectiveness of extended-valency pneumococcal conjugate vaccines" 대한소아과학회 57 (57): 55-66, 2014

      38 Yun JM, "Effect of public disclosure on antibiotic prescription rate for upper respiratory tract infections" 175 : 445-447, 2015

      39 Lee EK, "Drug use evaluation" Korea Institute for Health and Social Affairs 2000

      40 Cho HJ, "Discolored nasal discharge did not increase the antibiotic prescription rate for the common cold patients" 14 : 139-141, 2005

      41 Kang HY, "Consumer use of publicly released hospital performance information: assessment of the National Hospital Evaluation Program in Korea" 89 : 174-183, 2009

      42 Health Insurance Review and Assessment Service, "Comprehensive quality report of National Health Insurance 2010" Health Insurance Review and Assessment Service 2010

      43 Cho HJ, "Comparison of prescription behaviors between practicing physicians and pharmacists by simulated patients with common cold" 22 : 1394-1399, 2001

      44 DeMuri GP, "Clinical practice. Acute bacterial sinusitis in children" 367 : 1128-1134, 2012

      45 Shulman ST, "Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America" 55 : 1279-1282, 2012

      46 Huttner B, "Characteristics and outcomes of public campaigns aimed at improving the use of antibiotics in outpatients in high-income countries" 10 : 17-31, 2010

      47 Kim SH, "Changing trends in antimicrobial resistance and serotypes of Streptococcus pneumoniae isolates in Asian countries: an Asian Network for Surveillance of Resistant Pathogens (ANSORP)study" 56 : 1418-1426, 2012

      48 Xiao Y, "Changes in Chinese policies to promote the rational use of antibiotics" 10 : e1001556-, 2013

      49 Chong Y, "Capsular types and antimicrobial resistance of Streptococcus pneumoniae isolated in Korea" 14 : 528-531, 1995

      50 MacDougall C, "Antimicrobial stewardship programs in health care systems" 18 : 638-656, 2005

      51 World Health Organization, "Antimicrobial resistance:global report on surveillance, 2014"

      52 Uh GS, "Antibiotics prescription pattern of family practitioners for re-1, Antimicrobial resistance:global report on surveillance, 2014" World Health Organization

      53 Panasiuk L, "Antibiotics in the treatment of upper respiratory tract infections in Poland. Is there any improvement?" 35 : 665-669, 2010

      54 Nadeem Ahmed M, "Antibiotic prescription pattern for viral respiratory illness in emergency room and ambulatory care settings" 49 : 542-547, 2010

      55 Murphy M, "Antibiotic prescribing in primary care, adherence to guidelines and unnecessary prescribing--an Irish perspective" 13 : 43-, 2012

      56 Hong SI, "Analysis of antimicrobial susceptibility patterns of various microorganisms isolated from Seoul National University Hospital: statistical analysis on various clinical isolates during resecent 4 years (1980-1983)" 4 : 149-162, 1984

      57 Health Insurance Review and Assessment Service, "Analysis and evaluation of antibiotic use" Health Insurance Review and Assessment Service 2006

      58 Goossens H, "Achievements of the Belgian Antibiotic Policy Coordination Committee (BAPCOC)" 13 : 19036-, 2008

      59 이혁민, "2005∼2006년 국내 12개 병원에서 분리된 주요 세균의 항균제 내성률" 대한임상미생물학회 10 (10): 59-69, 2007

      60 정형준, "1차 의료기관에서 코감기에 처방한 항균제" 대한감염학회 39 (39): 125-132, 2007

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2011-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2010-02-25 학술지명변경 한글명 : 감염과화학요법 -> Infection and Chemotherapy
      외국어명 : Infection and Chemotherapy -> 미등록
      KCI등재후보
      2010-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2009-08-25 학술지명변경 외국어명 : 미등록 -> Infection and Chemotherapy KCI등재후보
      2008-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      2008-01-01 평가 등재후보 탈락 (등재후보1차)
      2006-01-01 평가 등재후보 1차 FAIL (등재후보2차) KCI등재후보
      2005-05-27 학술지등록 한글명 : 감염과화학요법
      외국어명 : 미등록
      KCI등재후보
      2005-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2004-01-01 평가 등재후보 1차 FAIL (등재후보1차) KCI등재후보
      2002-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.24 0.24 0.24
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.2 0.2 0.46 0.29
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼